Related Experiment Videos

Identification of patients at risk of ischemic events for long-term secondary prevention

Andrea Brassard1

  • 1Department of Nursing Education, The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA. npaaxb@gwumc.edu

Insights

Secondary ischemic events are preventable with lifestyle changes and pharmacotherapies for patients with atherothrombotic vascular disease. Nurse practitioners play a key role in ensuring effective secondary prevention strategies are implemented.

Area of Science:

  • Cardiovascular Medicine
  • Preventive Cardiology
  • Vascular Disease Management

Background:

  • Atherothrombotic vascular disease poses a significant risk for recurrent ischemic events.
  • Effective secondary prevention is crucial for managing patients with established atherosclerotic disease.

Purpose of the Study:

  • To review the identification of patients at risk for secondary ischemic events.
  • To discuss available medical therapies for secondary prevention.
  • To define the role of nurse practitioners in managing these patients.

Main Methods:

  • Review of ACC/AHA guidelines (2005-2007) for unstable angina, myocardial infarction, peripheral arterial disease, and ischemic stroke.
  • Inclusion of AHA/ACC 2006 guidelines update for coronary and atherosclerotic vascular disease.
  • Literature search using PubMed for relevant clinical articles.

Main Results:

  • Preventive therapy, including lifestyle modifications and pharmacotherapies (for dyslipidemia, diabetes, hypertension, platelet function), is critical.
  • Evidence indicates that secondary prevention strategies are not always effectively utilized.
  • Implementation of clinical practice guidelines can reduce recurrent atherothrombotic events.

Conclusions:

  • Nurse practitioners are well-positioned in primary and long-term care to assess and improve preventive care for patients with atherothrombotic vascular disease.
  • Increased awareness and adherence to clinical guidelines can significantly lower the risk of recurrent events.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...